These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3675613)

  • 1. Interaction of an intercalating antitumoral agent: 9-hydroxy-2-methyl ellipticinium (NMHE) with chromatin.
    Larue L; Quesne M; Paoletti J
    Biochem Pharmacol; 1987 Nov; 36(21):3563-9. PubMed ID: 3675613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accessibility to bacterial nucleic acids of the intercalating drug aliphatic amino acid ellipticinium derivatives in Escherichia coli and Salmonella typhimurium.
    Banoun H; Le Bret M; Auclair C
    Biochemistry; 1985 Jan; 24(3):701-7. PubMed ID: 3888261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-DNA interactions: spectroscopic and footprinting studies of site and sequence specificity of elliptinium.
    Mauffret O; Rene B; Convert O; Monnot M; Lescot E; Fermandjian S
    Biopolymers; 1991 Oct; 31(11):1325-41. PubMed ID: 1777583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of drug-DNA interactions: a comparative temperature jump study of ellipticinium and 9-hydroxy ellipticinium.
    Schwaller MA; Aubard J; Dodin G
    J Biomol Struct Dyn; 1988 Dec; 6(3):443-58. PubMed ID: 3271531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential scanning calorimetry of nuclei reveals the loss of major structural features in chromatin by brief nuclease treatment.
    Touchette NA; Cole RD
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2642-6. PubMed ID: 3857606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of isolated nuclei to phospholipid vesicles: analysis of chromatin sensitivity to DNase I and micrococcal nuclease.
    Cocco L; Gilmour RS; Papa S; Capitani S; Manzoli FA
    Cell Biol Int Rep; 1984 Jan; 8(1):55-63. PubMed ID: 6231116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclease sensitivity of active chromatin.
    Gazit B; Cedar H
    Nucleic Acids Res; 1980 Nov; 8(22):5143-55. PubMed ID: 6258137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ellipticine derivatives with an affinity to the estrogen receptor, an approach to develop intercalating drugs with a specific effect on the hormone-dependent breast cancer.
    Delbarre A; Oberlin R; Roques BP; Borgna JL; Rochefort H; Le Pecq JB; Jacquemin-Sablon A
    J Med Chem; 1985 Jun; 28(6):752-61. PubMed ID: 4009597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxidase-catalyzed covalent binding of the antitumor drug N2-methyl-9-hydroxyellipticinium to DNA in vitro.
    Auclair C; Dugué B; Meunier B; Paoletti C
    Biochemistry; 1986 Mar; 25(6):1240-5. PubMed ID: 3964674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the sensitivity of chromatin to exogenous nucleases: implications for the apparent increased sensitivity of transcriptionally active genes.
    Walker PR; Sikorska M
    Biochemistry; 1986 Jul; 25(13):3839-45. PubMed ID: 3091066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of cis-diamminedichloroplatinum (II) to chromatin. Specificity of the drug distribution.
    Foka M; Paoletti J
    Biochem Pharmacol; 1986 Oct; 35(19):3283-91. PubMed ID: 3768022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of chicken erythrocyte nuclei upon limited micrococcal nuclease digestion. Correlation with higher order chromatin structure.
    Hyde JE
    Exp Cell Res; 1982 Jul; 140(1):63-70. PubMed ID: 6286334
    [No Abstract]   [Full Text] [Related]  

  • 13. Virostatic in vivo effect of elliptinium on Friend's retrovirus (a model for HIV infection).
    Mathé G; Chenu E; Bourut C
    Biomed Pharmacother; 1990; 44(1):1-3. PubMed ID: 1369686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of chromatin structural transitions by means of intercalator dyes.
    Krajewski WA; Lagarkova MA; Sharova NP; Stolyarov SD; Ausio J
    Dokl Biochem Biophys; 2001; 378():150-2. PubMed ID: 11712165
    [No Abstract]   [Full Text] [Related]  

  • 15. Alteration of chromatin structure induced by the binding of adriamycin, daunorubicin and ethidium bromide.
    Grimmond HE; Beerman T
    Biochem Pharmacol; 1982 Nov; 31(21):3379-86. PubMed ID: 7150361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attempts to target antitumor drugs toward opioid receptor-rich mouse tumor cells with enkephalin-ellipticinium conjugates.
    Rigaudy P; Charcosset JY; Garbay-Jaureguiberry C; Jacquemin-Sablon A; Roques BP
    Cancer Res; 1989 Apr; 49(7):1836-42. PubMed ID: 2538235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of non-histone proteins between micrococcal nuclease sensitive and nuclease resistant chromatin from chicken cells with active and inactive genomes.
    Kiliańska Z; Kłyszejko-Stefanowicz L
    Cell Biochem Funct; 1984 Apr; 2(2):78-84. PubMed ID: 6467518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study, at the gene level, of the activation of topoisomerase II by antitumor agents].
    Vilarem MJ; Riou JF; Riou G; Larsen CJ
    Pathol Biol (Paris); 1987 Nov; 35(9):1263-9. PubMed ID: 2827094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HCl.
    Auclair C; Pierre A; Voisin E; Pepin O; Cros S; Colas C; Saucier JM; Verschuere B; Gros P; Paoletti C
    Cancer Res; 1987 Dec; 47(23):6254-61. PubMed ID: 3677074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a new DNA intercalating fluorescing probe for studies on the mechanism of frameshift mutagenesis in Salmonella typhimurium.
    René B; Banoun H; Auclair C; Paoletti C
    Biochimie; 1985; 67(3-4):327-34. PubMed ID: 3899187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.